These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
176 related items for PubMed ID: 23597147
1. Open label study of escalating doses of oral treprostinil diethanolamine in patients with systemic sclerosis and digital ischemia: pharmacokinetics and correlation with digital perfusion. Shah AA, Schiopu E, Hummers LK, Wade M, Phillips K, Anderson C, Wise R, Boin F, Seibold JR, Wigley F, Rollins KD. Arthritis Res Ther; 2013 Apr 18; 15(2):R54. PubMed ID: 23597147 [Abstract] [Full Text] [Related]
8. The Recurrence of Digital Ulcers in Patients with Systemic Sclerosis after Discontinuation of Oral Treprostinil. Shah AA, Schiopu E, Chatterjee S, Csuka ME, Frech T, Goldberg A, Spiera R, Peng SL, McBride RJ, Cleveland JM, Steen V. J Rheumatol; 2016 Sep 18; 43(9):1665-71. PubMed ID: 27307535 [Abstract] [Full Text] [Related]
9. Treprostinil Hydrogel Iontophoresis in Systemic Sclerosis-Related Digital Skin Ulcers: A Safety Study. Guigui A, Mazet R, Blaise S, Cracowski C, Beau-Guillaumot M, Kotzki S, Roustit M, Cracowski JL. J Clin Pharmacol; 2020 Jun 18; 60(6):758-767. PubMed ID: 32080862 [Abstract] [Full Text] [Related]
12. Treprostinil for the treatment of severe digital necrosis in systemic sclerosis. Engel G, Rockson SG. Vasc Med; 2005 Feb 18; 10(1):29-32. PubMed ID: 15920997 [Abstract] [Full Text] [Related]